<p>Hosts Jack West & Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform for systemic therapy, especially immunotherapy, in early stage cancer & pathologic response assessment from surgery.</p>

Hosts Jack West & Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform for systemic therapy, especially immunotherapy, in early stage cancer & pathologic response assessment from surgery.

<p>Hosts Jack West &amp; Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform for systemic therapy, especially immunotherapy, in early stage cancer &amp; pathologic response assessment from surgery.</p>

Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022

Oncologists H. Jack West from City of Hope Cancer Center & Charu Aggarwal from University of Pennsylvania bring a wide range of guests to discuss social media, digital education, and current controversies in cancer and medicine. Feedback and suggestions are welcomed at BeyondTheJournalShow@gmail.com

Medicine

Education

Oncologists H. Jack West from City of Hope Cancer Center &amp; Charu Aggarwal from University of Pennsylvania bring a wide range of guests to discuss social media, digital education, and current controversies in cancer and medicine. Feedback and suggestions are welcomed at BeyondTheJournalShow@gmail.com

Share Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022

Sign up to save your podcasts

Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022

Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022